Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.59 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.59 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.59 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.59 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.59 |
| ▸ | MAPT | P10636 | 2/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.59 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.59 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.59 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.59 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | CRHBP | P24387 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | ATM | Q13315 | 1/20 | 0.48 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.48 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.48 |
| ▸ | CA1 | P00915 | 1/20 | 0.46 |
| ▸ | CA2 | P00918 | 1/20 | 0.46 |
| ▸ | MGLL | Q99685 | 1/20 | 0.46 |
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12780891 | 1.00 | ALDH1A1 (0.59) | ALDH1A1TDP1L3MBTL1CYP1A2CYP3A4 | |
| SCHEMBL10066018 | 1.00 | ALDH1A1 (0.59) | ALDH1A1TDP1L3MBTL1CYP1A2CYP3A4 | |
| SCHEMBL14160254 | 1.00 | ALDH1A1 (0.59) | ALDH1A1TDP1L3MBTL1CYP1A2CYP3A4 | |
| SCHEMBL6140152 | 1.00 | ALDH1A1 (0.59) | ALDH1A1TDP1L3MBTL1CYP1A2CYP3A4 | |
| SCHEMBL24755117 | 1.00 | ALDH1A1 (0.59) | ALDH1A1TDP1L3MBTL1CYP1A2CYP3A4 | |
| SCHEMBL14160257 | 1.00 | ALDH1A1 (0.59) | ALDH1A1TDP1L3MBTL1CYP1A2CYP3A4 | |
| SCHEMBL24467954 | 1.00 | ALDH1A1 (0.59) | ALDH1A1TDP1L3MBTL1CYP1A2CYP3A4 | |
| SCHEMBL13854473 | 1.00 | ALDH1A1 (0.59) | ALDH1A1TDP1L3MBTL1CYP1A2CYP3A4 | |
| SCHEMBL22972387 | 1.00 | ALDH1A1 (0.59) | ALDH1A1TDP1L3MBTL1CYP1A2CYP3A4 | |
| SCHEMBL13020806 | 1.00 | ALDH1A1 (0.59) | ALDH1A1TDP1L3MBTL1CYP1A2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11825736-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2023-11-21 | — | — | US | disclosed |
| US-11825736-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2023-11-21 | — | — | US | disclosed |
| US-10941170-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2021-03-09 | — | — | US | disclosed |
| US-20200161568-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2020-05-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11825736-B2 | Organic electroluminescent materials and devices | IK, NDUFS3, NDUFV2 | ALDH1A1 123/4885TDP1 3184/4885L3MBTL1 2720/4885 |
| US-10941170-B2 | Organic electroluminescent materials and devices | OCIAD2, OCIAD1, NUDT1 | ALDH1A1 1882/4885TDP1 2054/4885L3MBTL1 1448/4885 |
| US-20200161568-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | IK, NDUFS3, NDUFV2 | ALDH1A1 123/4885TDP1 3184/4885L3MBTL1 2720/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.